CHM chimeric therapeutics limited

yes the problem isn’t the science, it’s the whole Paul hopper...

  1. 2,585 Posts.
    lightbulb Created with Sketch. 275
    yes the problem isn’t the science, it’s the whole Paul hopper portfolio, it doesn’t take much to work out he sells out his own companies to Soph’s and burns retail along the way, two of his companies down over 90% in two years while its peers are thriving

    compare rad to cu6 for example

    the constan CR’s, discounts and dilution has decimated the SP
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $46.58K 11.64M

Buyers (Bids)

No. Vol. Price($)
2 2545728 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 14771167 22
View Market Depth
Last trade - 16.10pm 19/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.